ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,456, issued on April 21, was assigned to Utah Valley University (Orem, Utah).

"Composition and method for HIP1-targeting inhibitor compounds" was invented by Nathan E. Goldfarb (Orem, Utah), Andrew Abell (Adelaide, Australia), Nicholas Schumann (Adelaide, Australia) and Borja Lopez Perez (Santiago de Compostela, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is an inhibitor compound targeting Hip1, with the inhibitor compound comprising a tripeptide targeting sequence that directs the compound to the active site of Hip1 and a C-terminal electrophilic warhead conjugated to the targeting sequence, the warhead configured to inact...